VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 59 filers reported holding VIRIDIAN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $56,477,999 | -1.7% | 3,681,747 | +52.4% | 3.83% | -13.7% |
| Q2 2023 | $57,458,940 | +8.3% | 2,415,256 | +15.8% | 4.44% | -11.7% |
| Q1 2023 | $53,060,157 | +3.7% | 2,085,698 | +19.1% | 5.03% | -16.2% |
| Q4 2022 | $51,151,588 | +52.4% | 1,751,167 | +7.0% | 6.00% | +34.2% |
| Q3 2022 | $33,559,000 | +122.0% | 1,636,211 | +25.2% | 4.47% | +48.4% |
| Q2 2022 | $15,117,000 | -34.9% | 1,306,569 | +4.0% | 3.01% | -50.9% |
| Q1 2022 | $23,224,000 | -2.8% | 1,256,051 | +3.9% | 6.14% | -10.0% |
| Q4 2021 | $23,903,000 | – | 1,209,051 | – | 6.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 680,768 | $11,376,000 | 2.18% |
| COMMODORE CAPITAL LP | 185,781 | $3,104,000 | 1.24% |
| Ghost Tree Capital, LLC | 300,000 | $5,013,000 | 1.18% |
| Logos Global Management LP | 550,000 | $9,191,000 | 0.90% |
| Atlas Venture Advisors, Inc. | 209,505 | $3,501,000 | 0.65% |
| BVF INC/IL | 463,504 | $7,745,000 | 0.29% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 27,586 | $461,000 | 0.25% |
| Fairmount Funds Management LLC | 35,092 | $581,000 | 0.24% |
| Soleus Capital Management, L.P. | 67,685 | $1,131,000 | 0.20% |
| Cormorant Asset Management, LP | 459,144 | $7,672,000 | 0.17% |